BlueSpruce Investments Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$76.9M |
| 2 |
Boston Scientific
BSX
|
+$24.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$612M |
| 2 |
TSMC
TSM
|
+$582M |
| 3 |
Amazon
AMZN
|
+$532M |
| 4 |
Meta Platforms (Facebook)
META
|
+$435M |
| 5 |
Stryker
SYK
|
+$268M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 28.8% |
| 2 | Consumer Discretionary | 20.46% |
| 3 | Technology | 18.35% |
| 4 | Healthcare | 17.19% |
| 5 | Financials | 15.2% |
Similar funds
BlueSpruce Investments's Q1 2026 Portfolio in Review
As of Q1 2026, BlueSpruce Investments held 11 positions worth $631M, down 84% from $3.92B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
BlueSpruce Investments withdrew a net $3.11B in Q1 2026, closing 1 position and reducing 8 holdings. Its most notable exit was Thermo Fisher Scientific, an estimated $231M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 29% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, BlueSpruce Investments opened a new position in Alphabet (Google) Class A worth $70.3M.
- BlueSpruce Investments's largest Q1 2026 buy was Alphabet (Google) Class A: 244,621 shares worth $70.3M.
- BlueSpruce Investments's biggest Q1 2026 reduction was Microsoft, cutting an estimated $612M.
- BlueSpruce Investments fully exited Thermo Fisher Scientific in Q1 2026, selling an estimated $231M.
- BlueSpruce Investments's ten largest holdings make up 100% of its $631M portfolio in Q1 2026.
- BlueSpruce Investments opened 2 new positions and closed 1 in Q1 2026.
- BlueSpruce Investments's portfolio value fell 84% quarter-over-quarter to $631M.
Based on BlueSpruce Investments's 13F filing for Q1 2026, filed 15 May 2026.